Edwards Lifesciences
851 hedge funds and large institutions have $30.6B invested in Edwards Lifesciences in 2018 Q3 according to their latest regulatory filings, with 91 funds opening new positions, 270 increasing their positions, 325 reducing their positions, and 70 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
1.86% more ownership
Funds ownership: 249.96% → 251.82% (+1.9%)
2% more funds holding
Funds holding: 837 → 851 (+14)
17% less repeat investments, than reductions
Existing positions increased: 270 | Existing positions reduced: 325
Holders
851
Holding in Top 10
23
Calls
$374M
Puts
$244M
Top Buyers
| 1 | +$384M | |
| 2 | +$254M | |
| 3 | +$235M | |
| 4 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
+$124M |
| 5 |
Jennison Associates
New York
|
+$104M |
Top Sellers
| 1 | -$146M | |
| 2 | -$103M | |
| 3 | -$94.5M | |
| 4 |
Renaissance Technologies
New York
|
-$72M |
| 5 |
WCM Investment Management
Laguna Beach,
California
|
-$66.3M |